COLUMBIA, SC, UNITED STATES, March 26, 2025 / EINPresswire.com / -- ClearPoint Health invites benefit advisors, human resources professionals, and employers to a free webinar event celebrating the ...
Joseph Michael Burnett, CEO, described 2025 as the start of ClearPoint Neuro’s “third phase,” called Fast. Forward., emphasizing an expanded commitment to cell and gene therapy, workflow ...
Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation Under the terms of the merger agreement ...